Analyst Coverage

Starpharma is covered by research analysts, including:

 

Firm Analyst
Nomura David Stanton / Zara Lyons
Bell Potter Stuart Roberts
Shaw Stockbroking Mathijs Smith
Morningstar James Cooper
Bioshares (Sector Analysis) David Blake / Mark Pachacz

 

 

 

 

 

 

 

 

Please note that any opinions, estimates or forecasts regarding Starpharma's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Starpharma or its management. Starpharma does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Starpharma cannot guarantee its accuracy.

 

Nomura Equity Research initiated coverage in November 2011
Access the report from Nomura's website
Nomura Update February 1, 2012 - Positive preclinicals for dendrimer-docetaxel

© Starpharma Holdings Limited 2011